- Biosimilars and Generic Drugs in Cancer Care🔍
- Generic drugs in oncology🔍
- Generic cancer drugs are still in short supply🔍
- Cancer Drugs🔍
- Cancer drugs A to Z list🔍
- As Drugmakers Abandon Cheap Generics🔍
- Why Are Generic Cancer Drugs Out of Reach for Many Patients?🔍
- The economic impact of the transition from branded to generic ...🔍
Generic drugs in oncology
Biosimilars and Generic Drugs in Cancer Care: What to Know
Brand-name drugs are either synthetic, made from a chemical process, or biological, made from living sources. Synthetic branded drugs may be ...
Generic drugs in oncology - The Lancet
The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees
Generic cancer drugs are still in short supply - Nelson - 2024
The ongoing shortage has forced hospitals to continue rationing drugs and prompted new calls for federal investment and long-term solutions.
K · Kadcyla (Ado-Trastuzumab Emtansine) · Kepivance (Palifermin) · Keytruda (Pembrolizumab) · Kimmtrak (Tebentafusp-tebn) · Kisqali (Ribociclib Succinate) · Kisqali ...
O · Obinutuzumab (Gazyvaro) · Octreotide · Olaparib (Lynparza) · Ontruzant · Opdivo · Oramorph · Osimertinib (Tagrisso) · OxCap ...
As Drugmakers Abandon Cheap Generics, Cancer Patients Are Left ...
Cisplatin and carboplatin are among scores of drugs in shortage, including 12 other cancer drugs, attention-deficit/hyperactivity disorder pills ...
Why Are Generic Cancer Drugs Out of Reach for Many Patients?
Many patients with cancer may not be getting access to the off-brand drugs they need, either because certain long-standing generic drugs are in short supply.
The economic impact of the transition from branded to generic ...
In summary, generic versions of costly oncology drugs offer significantly improved cost-effectiveness and cost–utility. Generic versions of ...
Targeted Therapy Drug List by Cancer Type - NCI
Targeted therapy approved for solid tumors anywhere in the body · dabrafenib mesylate (Tafinlar) · dostarlimab-gxly (Jemperli) · entrectinib ( ...
Generic oncology drugs: are they all safe? - PubMed
Although the availability of generic oncology drugs allows access to contemporary care and reduces costs, there is international variability in the safety ...
Series Generic oncology drugs: are they all safe? - ScienceDirect.com
In this Series paper, we review clinical, policy, safety, and regulatory considerations for generic oncology drugs focusing on the USA, Canada, the European ...
Generic drugs in oncology – Authors' reply - The Lancet
We share the same view that generic oncology drugs are essential to the delivery of affordable cancer care in countries with strong regulatory systems.
Generics and Biosimilars Offer Savings for Patients Fighting Cancer ...
Generic and biosimilar medicines improve access and affordability for the millions of people with illnesses like asthma, arthritis, ...
Generic drugs: their role in better value cancer care
There is also a sense that, as a medical community, we have not capitalized on the potential for developing and rapidly assessing generic drugs after the period ...
Projected Savings for Generic Oncology Drugs Purchased via Mark ...
Replacing current Part D median formulary prices with MCCPDC pricing could yield significant savings for seven generic oncology drugs.
Strengthening the supply chain for cancer drugs | OSTP
Three of these drugs—cisplatin, carboplatin, and methotrexate—are widely used generic drugs and have been staples of cancer treatment for ...
Generic oncology drugs: are they all safe? - ScienceDirect
In this Series paper, we review clinical, policy, safety, and regulatory considerations for generic oncology drugs focusing on the USA, Canada, the European ...
Generic cancer drugs that we can trust | Cancer World Archive
Currently there are more than 60 imatinib and dasatinib generics – dasatinib (Sprycel) is another TKI used in first-line CML treatment – and ...
An Insurer's Program To Incentivize Generic Oncology Drugs Did ...
The main goal of the program was to promote the use of generic anticancer drugs without creating perverse financial incentives, while preserving ...
The role of generic medicines and biosimilars in oncology in low ...
The availability of affordable anti-cancer generic drugs and biologically similar therapeutic agents (biosimilars) will go a long way to reduce overall cost of ...